hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel

RxCUI: 1012223
RxNorm name: hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel
Display name: Hydrocortisone/Lidocaine (Rectal)
Full name: hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel
Term type: SCD
Status: Active
Strength: 2.5-3%
Dose form: Gel
Route: Rectal
Updated: 2026-06-16 07:06:26

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 102010
Active start: 102010
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
hydrocortisone acetate	0.025 MG / 1 MG	hydrocortisone	hydrocortisone acetate
lidocaine hydrochloride	0.03 MG / 1 MG	lidocaine	lidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Rectal Gel	346170

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
hydrocortisone	5492
lidocaine	6387

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel	1	NAMES
RxNorm Name	hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel	1	NAMES
RxNorm Synonym	hydrocortisone acetate 2.5 % / lidocaine HCl 3 % Rectal Gel	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	3 linked values 0db13203-e001-42fc-b3a2-7f189d171de3 21dcb757-1f7c-a4ca-e063-6394a90a456d fd6343a9-15a6-4894-b51f-122e4d6dbe79	3	CODES
RxCUI	1012223	1	CODES
MMSL_CODE	2 linked values BD16684 CD16684	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler
13925-164-20	13925-164	Lidocaine Hydrochloride and Hydrocortisone Acetate Lidocaine Hydrochloride and Hydrocortisone Acetate	Seton Pharmaceuticals
24470-964-20	24470-964	LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE	Cintex Services, LLC
59088-838-01	59088-838	Lidocaine HCl - Hydrocortisone Acetate Lidocaine HCl and Hydrocortisone Acetate	PureTek Corporation

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 17 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
13925016407	rxnav_ndcs	yes
13925016420	rxnav_ndcs	yes
24470096401	rxnav_ndcs	yes
24470096420	rxnav_ndcs	yes
59088083801	rxnav_ndcs	yes
59088083820	rxnav_ndcs	yes
18754048207	rxnav_historical
18754048220	rxnav_historical
24486040120	rxnav_historical
35356048607	rxnav_historical
49769019320	rxnav_historical
59088082200	rxnav_historical
65179030707	rxnav_historical
65179080407	rxnav_historical_indirect
65255014104	rxnav_historical
68032019301	rxnav_historical
68032019320	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine HCl - Hydrocortisone Acetate	LIDOCAINE HCL AND HYDROCORTISONE ACETATE	PureTek Corporation	0db13203-e001-42fc-b3a2-7f189d171de3	2025-01-09	Warnings, Adverse reactions	Exact identifier ndc (package): 59088-838-01 ndc (product): 59088-838 ndc11 (package): 59088083820 ndc11 (package): 59088083801 rxcui: 1012223
LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE	LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE	Cintex Services, LLC	21dcb757-1f7c-a4ca-e063-6394a90a456d	2024-09-17	Warnings, Adverse reactions	Exact identifier ndc (package): 24470-964-20 ndc (product): 24470-964 ndc11 (package): 24470096401 ndc11 (package): 24470096420 rxcui: 1012223
Lidocaine Hydrochloride and Hydrocortisone Acetate	LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE	Seton Pharmaceuticals	fd6343a9-15a6-4894-b51f-122e4d6dbe79	2024-01-30	Warnings, Adverse reactions	Exact identifier ndc (package): 13925-164-20 ndc (product): 13925-164 ndc11 (package): 13925016420 ndc11 (package): 13925016407 rxcui: 1012223

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
fd6343a9-15a6-4894-b51f-122e4d6dbe79	lidocaine HCl 3 % / hydrocortisone acetate 2.5 % Rectal Gel [PSN] · hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel [SCD] · hydrocortisone acetate 2.5 % / lidocaine HCl 3 % Rectal Gel [SY]	3	5	Lidocaine 3% - Hydrocortisone 2.5% Gel Kit	20240130
0db13203-e001-42fc-b3a2-7f189d171de3	lidocaine HCl 3 % / hydrocortisone acetate 2.5 % Rectal Gel [PSN] · hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel [SCD] · hydrocortisone acetate 2.5 % / lidocaine HCl 3 % Rectal Gel [SY]	3	3	Lidocaine HCl 3%- Hydrocortisone Acetate 2.5%	20250109
21dcb757-1f7c-a4ca-e063-6394a90a456d	lidocaine HCl 3 % / hydrocortisone acetate 2.5 % Rectal Gel [PSN] · hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel [SCD] · hydrocortisone acetate 2.5 % / lidocaine HCl 3 % Rectal Gel [SY]	3	2	Lidocaine 3% - Hydrocortisone 2.5% Gel Kit (lidocaine hydrochloride 3%, hydrocortisone acetate 2.5%) Anit-Inflammatory Anesthetic for Relief of Hemorrhoid Pain, Swelling and Inflammation	20240917

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
0db13203-e001-42fc-b3a2-7f189d171de3	Lidocaine HCl 3%- Hydrocortisone Acetate 2.5%	PureTek Corporation	20250109
21dcb757-1f7c-a4ca-e063-6394a90a456d	Lidocaine 3% - Hydrocortisone 2.5% Gel Kit (lidocaine hydrochloride 3%, hydrocortisone acetate 2.5%) Anit-Inflammatory Anesthetic for Relief of Hemorrhoid Pain, Swelling and Inflammation	Cintex Services, LLC	20240917
fd6343a9-15a6-4894-b51f-122e4d6dbe79	Lidocaine 3% - Hydrocortisone 2.5% Gel Kit	Seton Pharmaceuticals	20240130
6585c6d0-2603-45d8-b24c-d849dfdb9b99		National Council for Prescription Drug Programs	20120724
8b99e723-935a-43c2-8285-2695b227a45c		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N01BB	Amides	ATC1-4		lidocaine
ATC	S02DA	Analgesics and anesthetics	ATC1-4		lidocaine
ATC	D04AB	Anesthetics for topical use	ATC1-4		lidocaine
ATC	R02AD	Anesthetics, local	ATC1-4		lidocaine
ATC	C01BB	Antiarrhythmics, class Ib	ATC1-4		lidocaine
ATC	S02BA	Corticosteroids	ATC1-4		hydrocortisone
ATC	C05AA	Corticosteroids	ATC1-4		hydrocortisone
ATC	A07EA	Corticosteroids acting locally	ATC1-4		hydrocortisone
ATC	A01AC	Corticosteroids for local oral treatment	ATC1-4		hydrocortisone
ATC	S01BA	Corticosteroids, plain	ATC1-4		hydrocortisone
ATC	D07AA	Corticosteroids, weak (group I)	ATC1-4		hydrocortisone
ATC	D07XA	Corticosteroids, weak, other combinations	ATC1-4		hydrocortisone
ATC	S01CB	Corticosteroids/antiinfectives/mydriatics in combination	ATC1-4		hydrocortisone
ATC	H02AB	Glucocorticoids	ATC1-4		hydrocortisone
ATC	S01HA	Local anesthetics	ATC1-4		lidocaine
ATC	C05AD	Local anesthetics	ATC1-4		lidocaine
FDASPL	N0000175682	Amide Local Anesthetic	EPC	has_epc	lidocaine
FDASPL	N0000175426	Antiarrhythmic	EPC	has_epc	lidocaine
FDASPL	N0000175576	Corticosteroid	EPC	has_epc	hydrocortisone
FDASPL	N0000175976	Local Anesthesia	PE	has_pe	lidocaine
MEDRT	D006854	Hydrocortisone	CHEM	has_ingredient	hydrocortisone
MEDRT	D006854	Hydrocortisone	CHEM	has_ingredient	hydrocortisone acetate
MEDRT	D008012	Lidocaine	CHEM	has_ingredient	lidocaine hydrochloride
MEDRT	D008012	Lidocaine	CHEM	has_ingredient	lidocaine
MEDRT	D000219	Adams-Stokes Syndrome	DISEASE	ci_with	lidocaine
MEDRT	D000219	Adams-Stokes Syndrome	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D000312	Adrenal Hyperplasia, Congenital	DISEASE	may_treat	hydrocortisone
MEDRT	D000312	Adrenal Hyperplasia, Congenital	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D000309	Adrenal Insufficiency	DISEASE	may_treat	hydrocortisone
MEDRT	D000309	Adrenal Insufficiency	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D002056	Burns	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D002056	Burns	DISEASE	may_treat	lidocaine
MEDRT	D003093	Colitis, Ulcerative	DISEASE	may_treat	hydrocortisone
MEDRT	D003093	Colitis, Ulcerative	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D003877	Dermatitis, Contact	DISEASE	may_treat	hydrocortisone
MEDRT	D003877	Dermatitis, Contact	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	hydrocortisone
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	hydrocortisone acetate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hydrocortisone
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hydrocortisone acetate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	lidocaine
MEDRT	D064420	Drug-Related Side Effects and Adverse Reactions	DISEASE	may_treat	lidocaine
MEDRT	D064420	Drug-Related Side Effects and Adverse Reactions	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D004935	Esophageal Diseases	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D004935	Esophageal Diseases	DISEASE	may_treat	lidocaine
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	hydrocortisone
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	hydrocortisone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	hydrocortisone
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	hydrocortisone
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	lidocaine
MEDRT	D007249	Inflammation	DISEASE	may_treat	hydrocortisone
MEDRT	D007249	Inflammation	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	hydrocortisone
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D009059	Mouth Diseases	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D009059	Mouth Diseases	DISEASE	may_treat	lidocaine
MEDRT	D009203	Myocardial Infarction	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_prevent	lidocaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_prevent	lidocaine
MEDRT	D010146	Pain	DISEASE	may_treat	lidocaine
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	hydrocortisone
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D012216	Rheumatic Diseases	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D012216	Rheumatic Diseases	DISEASE	may_treat	hydrocortisone
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	hydrocortisone
MEDRT	D012769	Shock	DISEASE	may_treat	hydrocortisone
MEDRT	D012769	Shock	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D012876	Skin Diseases, Parasitic	DISEASE	ci_with	hydrocortisone
MEDRT	D012876	Skin Diseases, Parasitic	DISEASE	ci_with	hydrocortisone acetate
MEDRT	D017193	Skin Diseases, Viral	DISEASE	ci_with	hydrocortisone
MEDRT	D017193	Skin Diseases, Viral	DISEASE	ci_with	hydrocortisone acetate
MEDRT	D013224	Status Asthmaticus	DISEASE	may_treat	hydrocortisone
MEDRT	D013224	Status Asthmaticus	DISEASE	may_treat	hydrocortisone acetate
MEDRT	D013614	Tachycardia, Paroxysmal	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D013614	Tachycardia, Paroxysmal	DISEASE	may_treat	lidocaine
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	may_treat	lidocaine
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	hydrocortisone
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	hydrocortisone acetate
MEDRT	D018754	Ventricular Dysfunction	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D014693	Ventricular Fibrillation	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D014693	Ventricular Fibrillation	DISEASE	may_treat	lidocaine
MEDRT	D018879	Ventricular Premature Complexes	DISEASE	may_treat	lidocaine
MEDRT	D018879	Ventricular Premature Complexes	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	hydrocortisone acetate
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	hydrocortisone
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	hydrocortisone
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	hydrocortisone acetate
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	lidocaine hydrochloride
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	lidocaine
MEDRT	N0000008327	Carbohydrate Metabolism Alteration	PE	has_pe	hydrocortisone
MEDRT	N0000008327	Carbohydrate Metabolism Alteration	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008330	Cardiac Rhythm Alteration	PE	has_pe	lidocaine hydrochloride
MEDRT	N0000008330	Cardiac Rhythm Alteration	PE	has_pe	lidocaine
MEDRT	N0000010253	Decreased Capillary Permeability	PE	has_pe	hydrocortisone
MEDRT	N0000010253	Decreased Capillary Permeability	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008472	Decreased Cardiac Muscle Organized Electrical Activity	PE	has_pe	lidocaine hydrochloride
MEDRT	N0000008472	Decreased Cardiac Muscle Organized Electrical Activity	PE	has_pe	lidocaine
MEDRT	N0000010248	Decreased Fibroblast Migration	PE	has_pe	hydrocortisone
MEDRT	N0000010248	Decreased Fibroblast Migration	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008645	Decreased Glucocorticoid Secretion	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008645	Decreased Glucocorticoid Secretion	PE	has_pe	hydrocortisone
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	hydrocortisone
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008700	Decreased Lysosomal Function	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008700	Decreased Lysosomal Function	PE	has_pe	hydrocortisone
MEDRT	N0000010246	Decreased Polymorphonuclear Leukocyte Migration	PE	has_pe	hydrocortisone
MEDRT	N0000010246	Decreased Polymorphonuclear Leukocyte Migration	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	hydrocortisone acetate
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	hydrocortisone
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	hydrocortisone
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	hydrocortisone acetate

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Rectal Gel	rxnav_allrelated
DFG	DFG	Rectal Product	rxnav_allrelated
IN	IN	hydrocortisone	rxnav_allrelated
IN	IN	lidocaine	rxnav_allrelated
MIN	MIN	hydrocortisone / lidocaine	rxnav_allrelated
PIN	PIN	hydrocortisone acetate	rxnav_allrelated
PIN	PIN	lidocaine hydrochloride	rxnav_allrelated
SCD	SCD	hydrocortisone acetate 0.025 MG/MG / lidocaine hydrochloride 0.03 MG/MG Rectal Gel	rxnav_allrelated
SCDC	SCDC	hydrocortisone acetate 0.025 MG/MG	rxnav_allrelated
SCDC	SCDC	lidocaine hydrochloride 0.03 MG/MG	rxnav_allrelated
SCDF	SCDF	hydrocortisone / lidocaine Rectal Gel	rxnav_allrelated
SCDFP	SCDFP	hydrocortisone acetate / lidocaine hydrochloride Rectal Gel	rxnav_allrelated
SCDG	SCDG	hydrocortisone / lidocaine Rectal Product	rxnav_allrelated
SCDGP	SCDGP	hydrocortisone acetate / lidocaine hydrochloride Rectal Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.025 MG/MG (expressed as hydrocortisone acetate) / 0.03 MG/MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	VUID	4029487
NAMES	Prescribable Synonym	lidocaine HCl 3 % / hydrocortisone acetate 2.5 % Rectal Gel
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File